Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

Natl J Med Res. 2013; 3(3): 233-235


Comparison of Bronchodilatory Efficacy Potential of Racemic Salbutamol and Levosalbutamol in Patients with Mild to Moderate Persistant Asthama

Nimit V Khara, Anand K Patel, Kiran C Rami, Firoj D Ghanchi.

Abstract
Introduction: The World Health Organization has estimated that 15 million disability-adjusted life years (DALYs) are lost annually due to asthma, representing 1% of the total global disease burden. Racemic Salbutamol and Levo Salbutamol both have potent broncho-dilatory effect and therefore, both are used in the treatment of Asthma. The study was conducted to compare bronchodilatory efficacy potential of Salbutamol with Levo-Salbutamol.
Methodology: The present study was conducted among 100 patients at a tertiary care hospital mild to moderate persistent asthma. Patients were divided in two groups, 50 subjects in each group. After performing baseline spirometry, group A and group B subjects were given 2.5 mg salbutamol and 1.25 mg levosalbutamol, respectively, through nebulizer (continuous, compressor type of nebulizer with drug particle size 0.5-5 micron and average nebulization rate 0.2ml/min.). After 20 minutes, repeat spirometry was performed to measure bronchodilatory response.
Results: Two groups are comparable for base line characteristics, as there is no age & sex wise and symptom wise significant difference in the distribution of patients (p >0.05 for all variables). Overall picture is suggestive of no significant statistical difference in bronchodilatory potential between Salbutamol and Levo-Salbutamol. Positive raise in FEV1, FEV1/FVC% and PEFR is statistically not significant in both groups (P>0.05 for all three).
Conclusion: Salbutamol and Levo-Salbutamol had isoeffective bronchodilatory potential in bronchial asthma patients when used at equipotent doses.

Key words: Racemic Salbutamol, Levosalbutamol, Bronchodilator, Asthma



Share this Article


Advertisement
Journal of Interdisciplinary Histopathology

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.